Teladoc Health Announces Employee Inducement Awards Under NYSE Rule 303A.08
Rhea-AI Summary
Teladoc Health (NYSE:TDOC) has granted inducement awards to two new non-executive employees, effective November 1, 2024. The awards consist of restricted stock units covering 70,575 shares of common stock. The vesting schedule includes one-third of shares on the first anniversary, with the remaining shares vesting quarterly over the following two years. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.
Positive
- Strategic talent acquisition with equity-based compensation to align employee interests with shareholders
Negative
- Potential shareholder dilution from issuance of 70,575 new shares
News Market Reaction
On the day this news was published, TDOC declined 2.94%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
PURCHASE, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.
Effective November 1, 2024, in connection with commencing employment, two new non-executive employees of Teladoc Health were granted awards of restricted stock units covering an aggregate of 70,575 shares of Teladoc Health’s common stock, par value
About Teladoc Health
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com
Media:
Chris Stenrud
860-491-8821
pr@teladochealth.com